Table 1.
Patient Characteristics
| Total (N=1269) |
CLL/SLL (N=275) |
HL (N=127) |
NHL (N=867) |
|
|---|---|---|---|---|
| Age at diagnosis | ||||
| N | 1269 | 275 | 127 | 867 |
| Median | 61.0 | 64.0 | 39.0 | 62.0 |
| Range | (18.0-91.0) | (36.0-91.0) | (18.0-89.0) | (18.0-90.0) |
| Gender | ||||
| Female | 529 (42%) | 93 (34%) | 55 (43%) | 381 (44%) |
| Male | 740 (58%) | 182 (66%) | 72 (57%) | 486 (56%) |
| Highest education level | ||||
| Missing | 525 (41%) | 76 (28%) | 67 (53%) | 382 (44%) |
| High school or less | 208 (16%) | 54 (20%) | 13 (10%) | 141 (16%) |
| Some college/vocational school | 215 (17%) | 54 (20%) | 15 (12%) | 146 (17%) |
| College graduate or higher | 321 (25%) | 91 (33%) | 32 (25%) | 198 (23%) |
| Age Group | ||||
| ≤ 60 | 609 (48%) | 103 (38%) | 103 (81%) | 403 (47%) |
| > 60 | 660 (52%) | 172 (63%) | 24 (19%) | 464 (54%) |
| Ann Arbor Stage | ||||
| Missing | 283 (22%) | 275 (100%) | 1 (1%) | 7 (1%) |
| I-II | 357 (28%) | n/a | 72 (57%) | 285 (33%) |
| III-IV | 629 (50%) | n/a | 54 (43%) | 575 (66%) |
| Rai Stage | ||||
| Missing | 1012 (80%) | 18 (7%) | 127 (100%) | 867 (100%) |
| 0 | 123 (10%) | 123 (45%) | n/a | n/a |
| 1 | 108 (9%) | 108 (39%) | n/a | n/a |
| 2 | 18 (1%) | 18 (7%) | n/a | n/a |
| 3 | 2 (<1%) | 2 (1%) | n/a | n/a |
| 4 | 6 (1%) | 6 (2%) | n/a | n/a |
| IPI | ||||
| Missing | 516 (41%) | 275 (100%) | 0 (0%) | 241 (28%) |
| 0 | 115 (9%) | n/a | 46 (36%) | 69 (8%) |
| 1 | 198 (16%) | n/a | 46 (36%) | 152 (18%) |
| 2 | 208 (16%) | n/a | 20 (16%) | 188 (22%) |
| 3 | 146 (12%) | n/a | 9 (7%) | 137 (16%) |
| 4 | 78 (6%) | n/a | 6 (5%) | 72 (8%) |
| 5 | 8 (1%) | n/a | 0 (0%) | 8 (1%) |
| IPS | ||||
| N | 127 | n/a | 127 | n/a |
| Median | 3.0 | 3.0 | ||
| Range | (1.0-6.0) | (1.0-6.0) |
CLL/SLL: Chronic lymphocytic leukemia/Small lymphocytic lymphoma; HL: Hodgkin lymphoma; NHL: non-Hodgkin lymphoma; IPI: International Prognostic Index; IPS: International Prognostic Score for HL